Macroaxis: Personalized Investing
Simple Personalized Investing

RHC SHL PRY GXL Healthcare Exotic ISP Plastics 
Benchmark SP 500  1,650   0.91  Index Moved Down -0.06% ...


Processing
Collecting data for VGH

Vision valuation

 
 Companies |  Insiders  | Dashboard  
     

Vision Eye Institute

Stock@Australian Securities Exchange 
Australia AUD
     
Use Vision Eye Institute Limited (#AU000000VGH1AU) valuation together with your other stock asset holdings to protect against small markets fluctuations as well as to check it against diversification policy that fits your risk preferences.  Optimize Portfolio
Vision Eye Institute Limited is at this time anticipated to have takeover price of 10.49 M with market capitalization of 10.49 M, debt of 80.92 M, and cash on hands of 12.6 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Vision fundamentals before making investing decisions based on the enterprise value of the company
Takeover PriceMarket CapDebt ObligationsCash
10.49 M10.49 M80.92 M12.6 M

Vision Investor Information

The company has Price to Book (P/B) ratio of 0.19. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Vision Eye Institute Limited had not issued any dividends in recent years. Vision Eye Institute Limited, together with its subsidiaries, offer private ophthalmic services in Australia. For more information please call CA BBus at 61 3 8844 4000 or visit http://www.visioneyeinstitute.com.au.

Vision Asset Utilization

Vision Eye Institute utilizes its assets roughly 8.09 %, earning A$0.08 for each dollar of assets held by the company. An increasing assets utilization denotes the company is being more effective with each dollar of assets it has. In other words assets utilization of Vision shows how effective it operates for each dollar spent on its assets

Vision Profitability Analysis

The company reported revenue of 109.43 M. Net Income was 9.39 M with profit before overhead, payroll, taxes, and interest of 39 M.

Vision Debt Analysis

VISION GROUP HLDG has accumulated about 12.6 M in cash with 24.47 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08.
The company has accumulated 80.92 M in total debt with debt to equity ratio (D/E) of 1.23 which is about average as compared to similar companies. Vision Eye Institute Limited has Current Ratio of 0.66 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.

Vision Market Share

Vision Eye Institute Limited is rated below average in market capitalization category among related companies. Market capitalization of Hospitals industry is at this time estimated at about 14.79 Billion. Vision adds roughly 10.49 Million in market capitalization claiming only tiny portion of equities under Hospitals industry.
Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker

Vision Revenue

Based on latest financial disclosure Vision Eye Institute Limited reported 109.43 M of revenue. This is 97.63% lower than that of Healthcare sector, and 98.01% lower than that of Hospitals industry, The Revenue for all stocks is 98.63% higher than the company.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium